Study guide
4.5 Permanent Pacemakers, CRT and Device Troubleshooting
AACN Cardiac Medicine Certification CMC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview and the CMC Test Plan
1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them
2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease
2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy
3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease
3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup
4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions
4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation
5 Chapter 5: Vascular Conditions and Vascular Interventions
5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications
6 Chapter 6: Shock States and Mechanical Circulatory Support
6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD
7 Chapter 7: Cardiac Procedures and Structural Heart Interventions
7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications
8 Chapter 8: Cardiovascular Pharmacology
8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure
9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary
9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients
10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral
10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients
11 Chapter 11: Monitoring and Diagnostics
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography
12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions
12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease
4.5 Permanent Pacemakers, CRT and Device Troubleshooting
Key Takeaways Explain This Topic AI
Pacemaker function is designated by the 5-letter NBG code (Chamber Paced, Chamber Sensed, Response to Sensing, Rate Modulation, Multisite Pacing); for example, DDD paces and senses both atria and ventricles.
Failure to capture is evidenced by pacing spikes without subsequent P or QRS complexes, whereas failure to sense (undersensing) causes inappropriate pacing spikes on top of native T or QRS waves, risking R-on-T VF.
Oversensing occurs when the pacemaker inappropriately senses non-cardiac signals (muscle tremors, EMI) or T waves as cardiac depolarizations, resulting in under-pacing and unexpected pauses.
Application of a ring magnet over an ICD inhibits shock delivery and sensing features (preventing inappropriate shocks during electrocautery), while a magnet over a pacemaker forces asynchronous pacing (VOO/DOO mode) at a fixed rate.
CRT-P / CRT-D is indicated for patients with HFrEF (LVEF ≤ 35%), sinus rhythm, LBBB with QRS ≥ 150 ms, and NYHA Class II-IV symptoms despite optimal medical therapy, requiring >95-98% biventricular pacing capture for clinical response.
Last updated: August 2026
Pacemaker NBG Coding System & Pacing Modes
Artificial cardiac pacemakers deliver electrical stimuli to the myocardium to initiate depolarization when intrinsic conduction fails. Device function is standardized using the NASPE/BPEG (NBG) 5-letter generic code .
The NBG Code Structure
- Position I Position II Position III Position IV Position V
- Chamber(s) Paced Chamber(s) Sensed Response to Sensing Rate Modulation Multisite Pacing
- A = Atrium A = Atrium I = Inhibited R = Rate responsive A = Atrial
- V = Ventricle V = Ventricle T = Triggered O = None V = Ventricular
- D = Dual (A+V) D = Dual (A+V) D = Dual (I+T) D = Dual (A+V)
- O = None O = None O = None O = None
- Common Clinical Pacing Modes
DDD Mode (Dual-Chamber Pacing & Sensing): The most sophisticated physiological mode.
Paces both atrium and ventricle when intrinsic signals are absent.
Senses intrinsic atrial and ventricular activity.
Response: Inhibits atrial/ventricular output if native beats are sensed; triggers ventricular pacing after a sensed intrinsic atrial beat (maintaining physiological AV synchrony).
VVI Mode (Single-Chamber Ventricular): Paces and senses the ventricle; inhibited by native ventricular beats. Used commonly in patients with chronic permanent Atrial Fibrillation with slow ventricular response.
AAI Mode (Single-Chamber Atrial): Paces and senses the atrium; used in sick sinus syndrome with intact AV nodal conduction.
VOO / DOO (Asynchronous Pacing): Paces at a fixed rate regardless of underlying intrinsic cardiac activity. Senses nothing (Position II = O). Used during surgical procedures to protect against electromagnetic interference (EMI).
Troubleshooting Pacemaker Malfunctions
Recognizing pacemaker malfunction on telemetry is a core critical care nursing skill for the AACN CMC exam. Failure to Capture:
- | (Spike) | (Spike)
- | |
- -+-----------------------+-------------------------
- (No QRS follows spike) (No QRS follows spike)
Failure to Sense (Undersensing):
- (Native QRS) (Pacing Spike on T wave! Risk of R-on-T VF)
- | |
- /\ | /\ |
- / \ /\ / \ /\|
- -/----\-/--\-------/----\-/--|-------------------
- 1. Failure to Capture
Definition: The pacemaker delivers an electrical impulse (a pacing spike is clearly visible on ECG), but no myocardial depolarization follows (no P wave after an atrial spike, or no QRS complex after a ventricular spike).
Etiologies:
Lead dislodgement or micro-dislodgement from the endocardium.
Exit Block: Localized myocardial tissue edema, fibrosis, or ischemia at the lead tip raising the electrical threshold.
Electrolyte/Metabolic Derangements: Severe hyperkalemia , acidosis, or antiarrhythmic drug toxicity (e.g., flecainide).
Insufficient energy output setting (mA set below capture threshold).
Nursing Interventions: Increase output (mA) on temporary generator; turn patient onto left lateral decubitus position (may re-establish lead contact); check serum electrolytes (STAT potassium/ABG); obtain STAT chest X-ray to evaluate lead placement.
2. Failure to Sense (Undersensing)
Definition: The pacemaker fails to detect native cardiac electrical activity. As a result, it fires competitive pacing spikes randomly throughout the cardiac cycle, including inappropriately on top of native QRS complexes or T waves.
Lethal Complication: A pacing spike falling on the vulnerable T wave phase can trigger the R-on-T phenomenon , precipitating polymorphic VT or VF!
Etiologies: Sensitivity threshold set too HIGH (e.g., set to 5.0 mV instead of 2.0 mV, making the device less sensitive to low-amplitude native signals); lead displacement; low intrinsic signal amplitude (small EGM voltage).
Nursing Interventions: Increase sensitivity by LOWERING the numerical mV threshold (e.g., dial down from 5.0 mV to 1.5 mV so smaller intrinsic waves are sensed).
3. Oversensing
Definition: The pacemaker inappropriately senses non-cardiac signals (e.g., skeletal muscle artifact, pectoral muscle twitching, diaphragmatic movement, electromagnetic interference / EMI) or internal T waves as native depolarizations.
Clinical Result: The pacemaker is inappropriately inhibited , leading to unexpected pauses, dizziness, or syncope in pacemaker-dependent patients.
Etiologies: Sensitivity setting set too LOW (e.g., 0.5 mV, making the device overly sensitive to background noise); lead insulation breach causing wire noise.
Nursing Interventions: Decrease sensitivity by RAISING the numerical mV threshold (e.g., adjust from 0.5 mV up to 2.5 mV); eliminate external sources of EMI.
Temporary Pacing Modalities & Clinical Nursing Care
Temporary transcutaneous, transvenous and epicardial pacing — including threshold testing, the 2-3x safety margin, epicardial wire identification and the full capture/sensing troubleshooting matrix — is covered in depth in section 4.4. This section stays with permanently implanted devices.
Implantable Cardioverter-Defibrillators (ICD) & Magnet Protocols
ICD primary and secondary prevention thresholds, transvenous versus subcutaneous devices, tiered therapy, electrical storm, inappropriate shocks, wearable cardioverter defibrillators and the full magnet-effect comparison are covered in section 4.6. The one point to carry from here: a magnet over a pacemaker produces asynchronous pacing (VOO/DOO), whereas a magnet over an ICD suspends tachytherapy and does not change pacing behaviour — so a pacing-dependent ICD patient needs formal reprogramming, not a magnet.
Cardiac Resynchronization Therapy (CRT-P / CRT-D)
In patients with heart failure and Left Bundle Branch Block (LBBB), electrical propagation to the lateral wall of the left ventricle is markedly delayed relative to the right ventricle. This intraventricular dyssynchrony impairs ejection fraction, increases mitral regurgitation, and accelerates adverse LV remodeling.
CRT Indications (ACC/AHA/HFSA Guidelines)
Left Ventricular Ejection Fraction LVEF ≤ 35% .
Sinus Rhythm.
LBBB morphology with QRS duration ≥ 150 ms (Class I recommendation) or 120-149 ms (Class IIa).
NYHA Class II, III, or ambulatory Class IV symptoms despite maximal optimal medical therapy.
Lead Configuration & Biventricular Optimization
Three Leads:
Right Atrial (RA) lead.
Right Ventricular (RV) lead.
Left Ventricular (LV) lead: Threaded transvenously through the coronary sinus into a epicardial lateral or posterolateral vein branch of the left ventricle.
Biventricular Pacing Percentage Target: Clinical response and functional recovery depend on achieving > 95% to 98% continuous biventricular pacing . Frequent PVCs, rapid Atrial Fibrillation, or loss of LV capture reduce pacing percentage and eliminate CRT benefit, requiring aggressive antiarrhythmic therapy, AV nodal ablation, or device reprogramming.